Literature DB >> 1688655

gamma-Preprotachykinin-(72-92)-peptide amide: an endogenous preprotachykinin I gene-derived peptide that preferentially binds to neurokinin-2 receptors.

T V Dam1, Y Takeda, J E Krause, E Escher, R Quirion.   

Abstract

The presence of N-terminally extended forms of neurokinin A has recently been reported in the mammalian brain. Among them, gamma-preprotachykinin-(72-92)-peptide amide [gamma-PPT-(72-92)-NH2], a peptide derived by posttranslational processing of gamma-preprotachykinin, is most prominent. We report here that this peptide most likely acts on neurokinin-2 receptor sites since neurokinin A (a putative neurokinin-2 agonist) and gamma-PPT-(72-92)-NH2 are potent competitors of 125I-labeled gamma-PPT-(72-92)-NH2 binding whereas selective neurokinin-1 and -3 agonists are not. Moreover, the distribution of 125I-labeled gamma-PPT-(72-92)-NH2 and 125I-labeled neurokinin A binding sites are very similar in rat brain. On the other hand, 125I-labeled Bolton-Hunter-substance P (a neurokinin-1 ligand) and 125I-labeled Bolton-Hunter-eledoisin (a neurokinin-3 ligand) binding sites are differentially located in this tissue. Thus, it appears that gamma-PPT-(72-92)-NH2 binds to neurokinin-2 receptors and should be considered as a putative endogenous ligand for this receptor class.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688655      PMCID: PMC53239          DOI: 10.1073/pnas.87.1.246

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Neuropeptide K, scyliorhinin I and II: new tools in the tachykinin receptor field.

Authors:  J C Beaujouan; M Saffroy; F Petitet; Y Torrens; J Glowinski
Journal:  Eur J Pharmacol       Date:  1988-07-07       Impact factor: 4.432

3.  Dynorphin is a specific endogenous ligand of the kappa opioid receptor.

Authors:  C Chavkin; I F James; A Goldstein
Journal:  Science       Date:  1982-01-22       Impact factor: 47.728

Review 4.  Endogenous opioids: biology and function.

Authors:  H Akil; S J Watson; E Young; M E Lewis; H Khachaturian; J M Walker
Journal:  Annu Rev Neurosci       Date:  1984       Impact factor: 12.449

5.  Peptide E and other proenkephalin-derived peptides are potent kappa opiate receptor agonists.

Authors:  R Quirion; A S Weiss
Journal:  Peptides       Date:  1983 Jul-Aug       Impact factor: 3.750

Review 6.  Classification of opioid receptors.

Authors:  S J Paterson; L E Robson; H W Kosterlitz
Journal:  Br Med Bull       Date:  1983-01       Impact factor: 4.291

7.  [3H]neurokinin B and 125I-Bolton Hunter eledoisin label identical tachykinin binding sites in the rat brain.

Authors:  L Bergström; Y Torrens; M Saffroy; J C Beaujouan; S Lavielle; G Chassaing; J L Morgat; J Glowinski; A Marquet
Journal:  J Neurochem       Date:  1987-01       Impact factor: 5.372

8.  Ontogeny of substance P receptor binding sites in rat brain.

Authors:  R Quirion; T V Dam
Journal:  J Neurosci       Date:  1986-08       Impact factor: 6.167

9.  Structure and gene organization of bovine neuromedin K precursor.

Authors:  H Kotani; M Hoshimaru; H Nawa; S Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

10.  Neuropeptide-gamma: a peptide isolated from rabbit intestine that is derived from gamma-preprotachykinin.

Authors:  R Kage; G P McGregor; L Thim; J M Conlon
Journal:  J Neurochem       Date:  1988-05       Impact factor: 5.372

View more
  6 in total

1.  Intracerebroventricular responses to neuropeptide gamma in the conscious rat: characterization of its receptor with selective antagonists.

Authors:  P Picard; R Couture
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

2.  Cardiovascular responses to intrathecal neuropeptide gamma in conscious rats: receptor characterization and mechanism of action.

Authors:  P Poulat; J de Champlain; R Couture
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

3.  Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat.

Authors:  C Tschöpe; P Picard; J Culman; A Prat; K Itoi; D Regoli; T Unger; R Couture
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

4.  Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.

Authors:  O Piot; J Betschart; I Grall; S Ravard; C Garret; J C Blanchard
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

5.  Binding sites for [125I]-Bolton-Hunter scyliorhinin II in guinea-pig ileum: a radioligand binding, functional and autoradiographic study.

Authors:  C J Mussap; E Burcher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-09       Impact factor: 3.000

6.  Comparison of the effects of neuropeptide K and neuropeptide gamma with neurokinin A at NK2 receptors in the hamster urinary bladder.

Authors:  P L van Giersbergen; S A Shatzer; E Burcher; S H Buck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-01       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.